Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,888.80
(
-0.25%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
90.94
(
-1.86%
)
Bitcoin
76,005.01
(
2.90%
)
News Focus
News Focus
Post# of 257431
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 77032

Wednesday, 03/10/2010 12:01:21 AM

Wednesday, March 10, 2010 12:01:21 AM

Post# of 257431
FDA approves Botox for spasticity:

http://finance.yahoo.com/news/BOTOX-OnabotulinumtoxinA-bw-3010154108.html?x=0&.v=1

This is a modestly consequential approval for AGN. Although Botox has been used off-label for spasticity for many years, reimbursement has not been easy in this indication.

p.s. This approval came three weeks before the PDUFA date!


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today